SCHEMBL6837880

SCHEMBL6837880

COc1ccc(C=O)c2cc(C(=O)NC(C)c3ccccc3)oc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
HPGD P15428 2/20 0.49
LMNA P02545 2/20 0.49
GAA P10253 1/20 0.49
PKM P14618 1/20 0.49
THRB P10828 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
RCE1 Q9Y256 1/20 0.46
PDE10A Q9Y233 1/20 0.42
RAB9A P51151 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ROCK2 O75116 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837881 1.00 ALDH1A1 (0.49) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6836531 0.82 MAPT (0.52) ALDH1A1HPGDLMNAPKMTHRB
SCHEMBL6837748 0.82 ALDH1A1 (0.46) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837574 0.82 ALDH1A1 (0.46) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837747 0.82 ALDH1A1 (0.46) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837573 0.82 ALDH1A1 (0.46) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837619 0.81 LMNA (0.49) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837964 0.81 ALDH1A1 (0.47) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837621 0.81 LMNA (0.49) ALDH1A1HPGDLMNAGAAPKM
SCHEMBL6837966 0.81 ALDH1A1 (0.47) ALDH1A1HPGDLMNAGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 ALDH1A1 323/4885HPGD 713/4885LMNA 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.